Search results
Drug for rare form of Lou Gehrig’s disease OK'd by FDA
Associated Press via Yahoo News· 1 year agoFood and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form...
Deseret News archives: Lessons from Lou Gehrig’s life
Deseret News via Yahoo Sports· 1 week agoNew York Yankees' Lou Gehrig, the "Iron Horse," wipes away a tear while speaking during a sold-out...
Sandra Bullock's partner Bryan Randall died of ALS. Here's what to know about this ‘devastating’...
Yahoo Life Style via AOL· 9 months agoBryan Randall, Sandra Bullock's partner, has died of ALS. Here's what you need to know about Lou...
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
Associated Press via Yahoo News· 7 months agoThe Food and Drug Administration meets this week to consider approval of an experimental treatment...
Huntington's vs. ALS: What Are the Differences?
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Lindsay Cook, PharmD Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS) are progressive neurodegenerative...
ALS drug from Mass.-based pharmaceutical wins FDA approval despite questionable data
WFXT via Yahoo News· 2 years agoA much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for...
Biotech Stocks Embrace The Neuroscience Renaissance With Biogen, Amylyx At The Helm
Investor's Business Daily· 1 year agoThe complexities of the human brain have perplexed drugmakers for years, but a slew of recent...
Signs and Symptoms of Amyotrophic Lateral Sclerosis (ALS)
Health via Yahoo News· 2 months agoMedically reviewed by Smita Patel, DO Formerly known as Lou Gehrig’s disease, amyotrophic lateral...
FDA panel backs much-debated ALS drug in rare, 2nd review
WFXT via Yahoo News· 2 years agoWASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an...
FDA still skeptical of ALS drug ahead of high-stakes meeting
Associated Press via Yahoo News· 2 years agoFederal health regulators remain unconvinced about the benefits of a closely watched experimental...